Linagliptin 668270-12-0 99%

CTX Lifesciences, headquartered in Surat (Gujarat, India), was established in 2004 as a vertically integrated API and intermediate manufacturing company.  It belongs to the privately owned Colourtex Industries Pvt Ltd, a group worth US$ 600 million, founded by Jayantibhai Jariwala in 1967.  Colourtex has grown to become one of the largest dyestuff manufacturers, offering an extensive range of dyes and performance chemicals for every fiber.  Leveraging its vast knowledge and in-depth understanding of the Chemical Sector, the Group ventured into the Pharmaceutical API & Intermediate market in 2004, launching CTX Lifesciences.

CTX’s Surat Facility boasts over 1000 KL of total reactor volume capacity, distributed through five manufacturing blocks.  Spanning 38 acres, the facility complies with USFDA, holds EU GMP and WHO GMP certifications, and has earned accreditations from various international drug authorities.  Moreover, CTX holds ISO 14001:2015 and ISO 45001:2018 certifications and is a Pharmaceutical Supply Chain Initiative (PSCI) audited and Ecovadis Bronze Rated company.

CTX is vertically integrated and manufactures Key Starting Material and Intermediates for the products, ensuring consistent quality and reliable supplies for all its key partners.  CTX is an extremely environmentally conscious and ecologically responsible manufacturer.  It has access to its own infrastructure, including a landfill site, effluent treatment plant, Multi Effect Evaporator (MEE), and Agitated Thin Film Dryer (ATFD).